Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9a652d3fb63e6921579775d6eb0a3fa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A40-146 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8257 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8261 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-825 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H5-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 |
filingDate |
2000-02-11^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2001-10-09^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b63445cb7d81dc7c70e6312657acf24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53adaad0bf1f3ff623cfc1282e469a13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed37bf8b3022e3be8682cf691ded9ff6 |
publicationDate |
2001-10-09^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6300134-B1 |
titleOfInvention |
RNA transformation vectors derived from a single-component RNA virus and contain an intervening sequence between the cap and the 5′ end |
abstract |
This invention is directed to a plus strand RNA viral vector for transformation of a host organism with a foreign RNA, and expression of said foreign RNA. The foreign RNA is inserted into an infective RNA viral segment containing cis-acting viral replication elements, and allowed to infect the host organism. The RNA vector is modified to obtain infectivity by including an intervening sequence between the cap and the 5' end. The modified RNA is able to tolerate the exogeneous RNA segment without disrupting the replication of the modified RNA, in the absence of a trans-acting viral replication element in a single component plant virus host cell. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010071085-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003097683-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8936937-B2 |
priorityDate |
1998-01-16^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |